TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | -9 | -7 | -39 | -17 | -23 | 0 | -19 |
| P | %wins | 0 | 0 | 0 | 0 | 0 | 0 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/22/24 17:31 | 10/15/24 | CAMP | Camp4 Therapeutics Corp | DE | Health | Drug | Pharmaceutical Preparations | Polaris Management Co. Vii, L.L.C. | MA | T | P.ad | 10,000 | 11.00 | 0 | 909 | New | 909 | I | |||||||||||||||
10/15/24 18:00 | 10/15/24 | CAMP | Camp4 Therapeutics Corp | DE | Health | Drug | Pharmaceutical Preparations | Polaris Management Co. Vii, L.L.C. | MA | T | P.d | 10,000 | 11.00 | 0 | 909 | New | 909 | I | |||||||||||||||
11/3/20 20:00 | 11/3/20 | SQZ | Sqz Biotechnologies Co | DE | Health | BioPrd | Biological Products, (No Diag | Polaris Management Co. Vii, L.L.C. | MA | T | P.d | 4,000 | 16.00 | 0 | 250 | 11 | 2,549 | I | |||||||||||||||
9/22/20 17:12 | 9/18/20 | MTCR | Metacrine, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Polaris Management Co. Vii, L.L.C. | MA | T | P.d | 2,990 | 13.00 | 0 | 230 | 179 | I | ||||||||||||||||
7/7/16 17:41 | 7/6/16 | SYRS | Syros Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Polaris Management Co. Vii, L.L.C. | MA | T | P.d | 5,000 | 12.50 | 6 | 400 | 48 | I | -1 | -9 | -7 | -39 | -17 | -23 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |